A plasma fatty acid profile associated to type 2 diabetes development: from the CORDIOPREV study.

Purpose: The prevalence of type 2 diabetes mellitus (T2DM) is increasing worldwide. For this reason, it is essential to identify biomarkers for the early detection of T2DM risk and/or for a better prognosis of T2DM. We aimed to identify a plasma fatty acid (FA) profile associated with T2DM developme...

Full description

Bibliographic Details
Published in:European Journal of Nutrition Vol. 61; no. 2; pp. 843 - 858
Main Authors: Villasanta-Gonzalez, Alejandro, Alcala-Diaz, Juan Francisco, Vals-Delgado, Cristina, Arenas, Antonio Pablo, Cardelo, Magdalena P., Romero-Cabrera, Juan Luis, Rodriguez-Cantalejo, Fernando, Delgado-Lista, Javier, Malagon, Maria M., Perez-Martinez, Pablo, Schulze, Matthias B., Camargo, Antonio, Lopez-Miranda, Jose
Format: research tables/charts Journal Article
Published: Springer Nature Mar2022
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155312850&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 155312850
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14366207
        CR0
      jtl: European Journal of Nutrition
      issn: 14366207
      maglogo: N
    pubinfo:
      dt: Mar2022
      vid: 61
      iid: 2
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        155312850
        152812800
        155312850
        155312850
        10.1007/s00394-021-02676-z
        155312850
      ppf: 843
      ppct: 15
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: A plasma fatty acid profile associated to type 2 diabetes development: from the CORDIOPREV study.
      aug:
        au:
          Villasanta-Gonzalez, Alejandro
          Alcala-Diaz, Juan Francisco
          Vals-Delgado, Cristina
          Arenas, Antonio Pablo
          Cardelo, Magdalena P.
          Romero-Cabrera, Juan Luis
          Rodriguez-Cantalejo, Fernando
          Delgado-Lista, Javier
          Malagon, Maria M.
          Perez-Martinez, Pablo
          Schulze, Matthias B.
          Camargo, Antonio
          Lopez-Miranda, Jose
        affil: Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Av. Menendez Pidal, s/n., 14004, Córdoba, Spain
      sug:
        subj:
          Fatty Acids Blood
          Biological Markers Blood
          Early Diagnosis
          Diabetes Mellitus, Type 2 Risk Factors
          Risk Assessment
          Diabetes Mellitus, Type 2 Prognosis
          Human
          Prevalence
          Cardiac Patients
          American Diabetes Association
          Descriptive Statistics
          Survival Analysis
          Confidence Intervals
          Prediction Models
      ab: Purpose: The prevalence of type 2 diabetes mellitus (T2DM) is increasing worldwide. For this reason, it is essential to identify biomarkers for the early detection of T2DM risk and/or for a better prognosis of T2DM. We aimed to identify a plasma fatty acid (FA) profile associated with T2DM development. Methods: We included 462 coronary heart disease patients from the CORDIOPREV study without T2DM at baseline. Of these, 107 patients developed T2DM according to the American Diabetes Association (ADA) diagnosis criteria after a median follow-up of 60 months. We performed a random classification of patients in a training set, used to build a FA Score, and a Validation set, in which we tested the FA Score. Results: FA selection with the highest prediction power was performed by random survival forest in the Training set, which yielded 4 out of the 24 FA: myristic, petroselinic, α-linolenic and arachidonic acids. We built a FA Score with the selected FA and observed that patients with a higher score presented a greater risk of T2DM development, with an HR of 3.15 (95% CI 2.04–3.37) in the Training set, and an HR of 2.14 (95% CI 1.50–2.84) in the Validation set, per standard deviation (SD) increase. Moreover, patients with a higher FA Score presented lower insulin sensitivity and higher hepatic insulin resistance (p < 0.05). Conclusion: Our results suggest that a detrimental FA plasma profile precedes the development of T2DM in patients with coronary heart disease, and that this FA profile can, therefore, be used as a predictive biomarker. Clinical Trials.gov.Identifier: NCT00924937.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N